The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Stadler, Walter M.
One or more keywords matched the following items that are connected to Stadler, Walter M.
Item TypeName
Concept Clinical Trials, Phase II as Topic
Academic Article Metastatic bladder cancer: advances in treatment.
Academic Article Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea.
Academic Article Gemcitabine doublets in advanced urothelial cancer.
Academic Article Randomized phase II trials and prostate-specific antigen endpoints in prostate cancer: much ado about nothing?
Academic Article Cytotoxic chemotherapy for metastatic renal cell carcinoma.
Academic Article Development of growth inhibitory agents in urological and other malignancies.
Academic Article The randomized discontinuation trial: a phase II design to assess growth-inhibitory agents.
Academic Article Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
Academic Article Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II?
Academic Article Developing drugs that do not cause tumor regression.
Academic Article Resampling phase III data to assess phase II trial designs and endpoints.
Academic Article Randomized phase II trials: a long-term investment with promising returns.
Academic Article Low-dose interleukin-2 in the treatment of metastatic renal-cell carcinoma.
Academic Article Other paradigms: randomized discontinuation trial design.
Academic Article Estimation of renal cell carcinoma treatment effects from disease progression modeling.
Academic Article Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.
Search Criteria
  • Clinical Trials Phase II as Topic